Updated:
SKS
SKS is a Chinese company founded in 2016 in Xian. It develops, produces, and sells organic chemicals, including new materials, biomedicines, and plant...
SKS
SKS is a Chinese company founded in 2016 in Xian. It develops, produces, and sells organic chemicals, including new materials, biomedicines, and plant protection chemicals.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Frequently asked questions
What investment strategies does SKS employ?
SKS deploys a generalist multi-strategy approach spanning buyouts, growth equity, secondaries, and corporate spin-offs. This combination allows the firm to pursue control transactions while also providing liquidity solutions to existing investors and corporate sellers. The spin-off focus is particularly relevant in Korea, where large conglomerates periodically divest non-core units.
Does SKS focus exclusively on South Korea, or does it invest elsewhere in Asia?
SKS concentrates its investment activity on the South Korean mid-market. The firm is headquartered in Seoul and targets domestic opportunities. There is no public indication of a multi-jurisdictional mandate extending to China, Japan, or Southeast Asia.
Who runs investment decisions at SKS?
Key principals and the investment committee composition at SKS are not publicly disclosed. The firm maintains a low external profile, consistent with many mid-market private equity managers operating in Korea's relationship-intensive financial landscape.
Is SKS a single-family office or an institutional asset manager?
SKS operates as an institutional asset manager, not a family office. The firm raises third-party capital for its buyout, growth, and secondaries strategies from external limited partners.
Does SKS participate in fund commitments or only direct deals?
SKS primarily executes direct transactions, including corporate carve-outs and growth equity placements. Its secondaries activity involves acquiring fund stakes from other investors, which suggests the firm evaluates both direct assets and fund-level exposures when sourcing deals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: